Top compounds associated with response to ZNF229


Feature Type Standardized
Nominal ANOVA
mRNA erismodegib CTRPv2 pan-cancer AAC -0.063 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.064 0.1
mRNA lovastatin CTRPv2 pan-cancer AAC -0.061 0.1
mRNA ML258 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.1
mRNA vincristine CTRPv2 pan-cancer AAC -0.05 0.1
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.071 0.1
mRNA KHS101 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
Download CSV